Cancer News and Research

Latest Cancer News and Research

New anti-tumor compounds show promise for hard-to-treat cancers

New anti-tumor compounds produced by Dr. Aleem Gangjee, Distinguished Professor of Medicinal Pharmacy at Duquesne University's Mylan School of Pharmacy, show such promise for fighting hard-to-treat tumors that the National Institutes of Health (NIH) has placed them on its fast track for development.

6 Jan 2012

Two non-profit organizations to address critical shortage of funding for pediatric cancer research

Two non-profit organizations committed to eliminating cancer in children and young adults have joined together to address the critical shortage of funding for pediatric cancer research.

6 Jan 2012

Combination of cancer drugs shows promise against Pompe disease

Kids with Pompe disease fail because of a missing enzyme, GAA, that leads to dangerous sugar build-up, which affects muscles and movement. An enzyme replacement treatment pioneered at Duke University has saved many lives, but some children with Pompe disease produce an immune reaction that blocks the benefits of the life-saving enzyme treatment.

6 Jan 2012

Baxter commences BAX 855 Phase I trial in hemophilia A

Baxter International Inc. today announced the dosing of the first patients in a Phase I clinical trial of its lead investigational candidate, BAX 855, a longer-acting (PEGylated) form of a full-length recombinant factor VIII (rFVIII) protein.

From Baxter International Inc. 5 Jan 2012

Cancer death rates declining - still room for improvement: Report

According to a new report from the American Cancer Society, fewer Americans are dying of cancer. The society's annual report on cancer statistics showed that cancer death rates have fallen nearly two percent for both men and women over the past five years. However experts warn that people still need to cut down their cancer risk.

5 Jan 2012

Loyola celebrates first baby of 2012

Ja'Nyah Crawford-Scotland was born at 11:01 a.m. on New Year's Day, the first baby to be born at Loyola University Medical Center in 2012. The healthy baby girl weighed 6 pounds, 3 ounces.

5 Jan 2012

Ipsen, Oncodesign partner to discover and develop LRRK2 kinase inhibitors against PD

Oncodesign, a Drug Discovery company and Oncology pharmacology service provider, and Ipsen, a global specialty-driven pharmaceutical company, announced today that the two companies have entered into a research collaboration to discover and develop innovative LRRK2 kinase inhibitors as potential therapeutic agents against Parkinson's Disease and for potential additional uses in other therapeutic areas.

5 Jan 2012

Midatech raises £6.3M through private investment round

Midatech Ltd., a global leader for the design, development, synthesis and manufacture of nanomedicines, announced today it has raised £6.3 million through a private investment round.

5 Jan 2012

Study refutes perinatal programming theory about adipose tissue growth

Is obesity in infants "programmed" in the womb? Previously, researchers assumed that consumption of "bad" fats during pregnancy contribute to excessive infant adipose tissue growth and that "good" omega-3 fatty acids prevent expansive adipose tissue development. A study run by the Technische Universit-t M-nchen showed no evidence to support this "perinatal programming" theory.

5 Jan 2012

Survey to help assess pediatric emergency readiness of hospital EDs

Marianne Gausche-Hill, M.D., and Kate Remick, M.D. - lead investigators at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) - are spearheading a statewide, web-based survey scheduled to roll out Jan. 6, 2012 that will help assess the pediatric emergency readiness of hospital emergency departments.

5 Jan 2012

One in six patients experience deterioration in quality of life after oesophageal cancer surgery

A new study published in the Journal of Clinical Oncology shows that most patients who survive for at least five years after oesophageal cancer surgery recover an average quality of life. However, quality of life deteriorates significantly for one in six patients to a level that remains much lower than the average population in the five years after surgery.

5 Jan 2012

Researchers urged to differentiate between two bladder cancer subtypes in their studies

Researchers are being urged to differentiate between two types of bladder cancer when they carry out studies, after a detailed trends analysis revealed significant differences between the main subtypes of the disease.

5 Jan 2012

Article focuses on new optical tools that use laser beams to peer painlessly below the skin

A hand-held scanner, reminiscent of the fictional Star Trek medical Tricorder, images blood vessels through the skin and projects a map onto the skin showing nurses exactly where to insert a needle.

5 Jan 2012

Driving in the mid-lane helps pensioners stay safe

It's official: older adults are naturally inclined to drive in the middle of the road, leaving the younger generation to cut corners. This tendency to sit mid-lane is an in-built safety mechanism that helps pensioners stay safe behind the wheel, according to researchers at the University of Leeds, UK.

5 Jan 2012

Daily doses of S-equol reduce hot flashes in postmenopausal women

Daily doses of a soy germ-based nutritional supplement containing S-equol significantly improved menopausal symptoms, including significantly reducing hot flash frequency after 12 weeks according to a placebo-controlled study in postmenopausal Japanese women published in the peer-reviewed Journal of Women's Health.

5 Jan 2012

ACS report shows decline in overall cancer death rates

The American Cancer Society's annual cancer statistics report shows that between 2004 and 2008, overall cancer incidence rates declined by 0.6% per year in men and were stable in women, while cancer death rates decreased by 1.8% per year in men and by 1.6% per year in women.

5 Jan 2012

New brochure makes planning and monitoring post-cancer exercise easy

Not only is overall quality of life higher in cancer survivors who exercise, but the rate of cancer recurrence is lower. Unfortunately, though most doctors recommend exercise, many patients fail to follow through.

5 Jan 2012

Celldex begins rindopepimut and Avastin Phase 2 combination trial in EGFRvIII-positive GB

Celldex Therapeutics, Inc. today announced that patient screening has initiated in a Phase 2 trial of rindopepimut in combination with Avastin in patients with recurrent epidermal growth factor variant III (EGFRvIII)-positive glioblastoma, called the "ReACT Study."

5 Jan 2012

Bionomics, Ironwood partner to develop and commercialize novel anti-anxiety compound

Ironwood Pharmaceuticals, Inc. and Bionomics Limited today announced that they entered into a collaboration, research, and licensing agreement that will enable Ironwood to develop and commercialize Bionomics' investigational anti-anxiety compound BNC210 and other related compounds.

5 Jan 2012

Antiestrogen supplements may reduce risk of melanoma in women with breast cancer

Women with breast cancer who take antiestrogen supplements may be decreasing their risk for melanoma, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.

5 Jan 2012

Cancer News and Research

Latest Cancer News and Research

New anti-tumor compounds show promise for hard-to-treat cancers

Two non-profit organizations to address critical shortage of funding for pediatric cancer research

Combination of cancer drugs shows promise against Pompe disease

Baxter commences BAX 855 Phase I trial in hemophilia A

Cancer death rates declining - still room for improvement: Report

Loyola celebrates first baby of 2012

Ipsen, Oncodesign partner to discover and develop LRRK2 kinase inhibitors against PD

Midatech raises £6.3M through private investment round

Study refutes perinatal programming theory about adipose tissue growth

Survey to help assess pediatric emergency readiness of hospital EDs

One in six patients experience deterioration in quality of life after oesophageal cancer surgery

Researchers urged to differentiate between two bladder cancer subtypes in their studies

Article focuses on new optical tools that use laser beams to peer painlessly below the skin

Driving in the mid-lane helps pensioners stay safe

Daily doses of S-equol reduce hot flashes in postmenopausal women

ACS report shows decline in overall cancer death rates

New brochure makes planning and monitoring post-cancer exercise easy

Celldex begins rindopepimut and Avastin Phase 2 combination trial in EGFRvIII-positive GB

Bionomics, Ironwood partner to develop and commercialize novel anti-anxiety compound

Antiestrogen supplements may reduce risk of melanoma in women with breast cancer

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in